ותק

3 שנים

קופות חולים

מאוחדת ,פרטי

תפקיד

בכיר במחלקת גסטרואנטרולוגיה, המרכז הרפואי שערי צדק

ניסיון קליני

11/83-10/84 Internship: Hadassah University Hospital, Jerusalem
12/84 Diploma: Docteur en Medecine, Paris. Thesis on : Brucellosis in Israel. Advisor: Prof J. Michel
1/85-6/87 Residency: Department of Internal Medicine, Hadassah Mount Scopus University Hospital, Jerusalem. Director: Prof Menczl
1991- Present: Senior Gastroenterologist in GI Unit, Shaare Zedek Medical Center
1992 -Present: Chief of Liver Clinic, Shaare Zedek
1993- Present: Consultant in Hepatology for Kupat Holim Mehouhedet, Jerusalem

השכלה

1970-1977 College: Paris, graduated with credit (main field: biology)
1977-1983 Medical School: Faculte de Medecine Xavier-Bichat, Universite Paris VII, France. Rotation of 6 months in Prof Benhamou’s Department of Hepatology, Hopital Beaujon

השתלמויות

7/87-6/89 (1) Department of Gastroenterology, Shaare Zedek Hospital, Jerusalem. Director: Dr Jacobsohn
7/89- 7/91 (2) Research and Clinical Fellowship in Hepatology, Department of Gastroenterology, Toronto General Hospital, Toronto, Canada. Director: Prof Blendis
1990-1991 Post-Doctoral Courses: 2 courses of statistics at the University of Toronto
for M.Sc
1998-2000 Ph. D in Philosophy at the faculte La Sorbonne, Paris I. Thesis on the body in Emmanuel Levinas’philosophy. Advisors: Prof F Bonnardel and Benny Levy

פרסומים מדעיים

1.Morali GA, Raz E. Wegener's granulomatosis. Harefuah 16:604-7, 1989 (Hebrew).
2.Barzilai N, Stesman NJ, Cohen P, Morali GA, Barzilai D, Karnieli E. Glucoregulatory hormone influence on hepatic production in the elderly. Age 12:13-7,1989.
3.Braverman DZ, Patz JK, Cartman G, Morali GA. Incompetence of the sphincter of Oddi in duodenal ulcer disease. Harefuah 119:424-5, 1990 (Hebrew).
4.Morali GA, Braverman DZ, Zimrn A, Gottschalk S, Dollberg M. Pneumatosis cystoides intestinalis of the splenic flexure. Harefuah 119:428-30,1990 (Hebrew).
5.Braverman DZ, Rodenski B, Dollberg L, Morali GA, Patz JK, Isacsohn M, Jacobsohn WZ. Campylobacter pylori in Israel: prospective study of prevalence and epidemiology. Isr J Med Sc 26:434-8,1990.
6.Morali GA, Braverman DZ, Lissi J, Goldstein R, Jacobsohn WZ. Effect of clonidine on gall bladder contraction and transit time in diabetic patients. Am J Gastroenterol 86:995-1000,1990.
7.Morali GA, Braverman DZ. Abnormal liver function tests and ketonuria in hyperemesis gravidarum. A survey of 80 cases. J Clin Gastroenterol 12:303-5,1990.
8.Braverman DZ, Stankiewicz H, Goldstein R, Patz JK, Morali GA, Jacobsohn WZ. Ornithine decarboxylase: an unreliable marker for the identification of population groups at risk for colonic neoplasia. Am J Gastroenterol 85:723-6,1990.
9.Warner LC, Campbell PJ, Morali GA, Logan AG, Skorecki KL, Blendis LM. The response of atrial natriuretic factor and sodium excretion to dietary sodium challenges in patients with chronic liver disease. Hepatology 12:4460-6,1990.
10.Maayan S, Morali GA, Engelhard D, Akerman Z, Gez E, Shapiro M, Bercovier H, Sacks T. Legionellosis at Hadassah University Hospital: a 1 year survey. Isr J Med Sci 27:145-9,1991.
11.Morali GA, Shemesh D, Braverman DZ, Abramovitch Z, Jacobsohn WZ. Successful treatment of a pancreatic pseudocyst with a somatostatin analogue and catheter drainage. Am J Gastroenterol 86:515-8,1991.
12.Floras JS, Legault L, Morali GA, Blendis LM. Direct evidence from intra-neural recordings for increased sympathetic outflow in patients with cirrhosis and ascites. Ann Intern Med 114:373-80,1991.
13.Warner LC, Morali GA, Miller JA, Logan AG, Skorecki KL, Blendis LM. Aldosterone, atrial natriuretic factor and sodium intake as determinants of the natriuretic response to headout water immersion in healthy human subjects. Clin Sci 80:475-80,1991.
14.Morali GA, Floras JS, Legault L, Tobe S, Logan AG, Skorecki KL, Blendis LM. Muscle sympathetic nerve activity and responsiveness to atrial natriuretic factor during the development of hepatic ascites. Am J Med 91:383-9,1991.
15.Morali GA, Sniderman K, Tobe S, Blendis LM, Is sinusoidal portal hypertension a necesssary factor for the development of hepatic ascites? J Hepatology 16:249-50,1992.
16.Morali GA, Tobe S, Skorecki KL, Blendis LM. Refractory ascites: modulation of ANF unresponsiveness by mannitol. Hepatology 16:42-8,1992.
17.Braverman DZ, Morali GA, Patz JK, Jacobsohn WZ. Is duodenal ulcer disease a seasonal disease? a retrospective endoscopic study of 3105 patients. Am J Gastroenterol 87:1591-3,1992.
18.Ynon AM, Morali GA, Goren A, Rodenski B, Isacsohn M, Michel J, Hershko C. Effect of age and duration of disease on the clinical manifestations of brucellosis. Is J Med Sc 29:11-6,1993.
19.Tobe S, Morali GA, Greig PD, Logan A, Blendis LM. Peritoneovenous shunting restores atrial natriuretic factor responsiveness in refractory hepatic ascites. Gastroenterology 105:202-7,1993.
20.Tobe SW, Blendis LM, Morali GA, Warner LC, Skorecki KL. Angiotensin II modulates ANF induced natriuresis in cirrhosis with ascite. Am J Kidn Dis 21:472-9,1993.
21.Morali GA, Liu P, Tobe S, Blendis LM. Measurement of central blood volume by radionuclide angiography in cirrhosis. Hepatology 19:312-21,1994.
22.Fernandez J, Morali GA, Wolever T, Blendis LM, Koo M, Jenkins DJ, Rao AV. Effect of acute lactulose administration on serum acetate in cirrhosis. Clin Invest Med 17:218-25,1994.
23.Bar Meir S, Chowers A, Morali G et al. Budesonide versus prednisone in the treatment of active Crohn's disease. Gastroenterology 1998;115:835-840
24. Breuer G, Morali G, Finkelstein Y. A pregnant woman with hepatitis A and Guillain Barre: A case report and review of the literature. Journal of Clinical Gastroenterology. 2000; in press
26.Legault L, Skorecki KL, Logan AG, Morali GA, Blendis LM. Volume expansion as a factor inducing a natriuresis in immersion resistant cirrhotic patients with ascites. Hepatology 10:718,1989.
27.Morali GA, Floras JS, Legault L, Logan AG, Skorecki KL, Blendis LM. Atrial natriuretic factor responsiveness in compensated and decompensated cirrhosis; the role of the sympathetic nervous system. Hepatology 12:856,1990.
28.Morali GA, Legault L, Skorecki KL, Logan AG, Blendis LM. Mechanisms of action of atrial natriuretic factor-induced natriuresis in cirrhosis. Hepatology 12:856,1990.
29.Morali GA, Legault L, Senn B, Blendis LM, Floras JS. Direct intra-neural recordings of muscle sympathetic nervous activity in cirrhosis. Hepatology 12:857,1990.
30.Morali GA, Legault L, Logan AG, Skorecki KL, Blendis LM. Intra-renal mechanisms of atrial natriuretic factor-induced natriuresis in cirrhosis. J Am Soc Nephrol 1:422,1990.
31.Morali GA, Legault L, Logan AG, Skorecki KL, Blendis LM. Atrial natriuretic factor infusion in cirrhosis with and without ascites. Clin Invest Med 13:B51,1990.
32.Morali GA, Sniderman K, Tobe S, Blendis LM. Is sinusoidal portalhypertension a necessary factor for the development of ascites? Hepatology 1991.
33.Morali GA, Tobe S, Greig PD, Blendis LM. Improvement of ANF responsiveness after peritoneovenous shunting (PVS) in refractory hepatic ascites. Hepatology 1991.
34.Morali GA, Tobe S, Skorecki KL, Blendis LM. Refractory ascites: modulation of ANF unresponsiveness by mannitol. Hepatology 1991.
35.Morali GA, Braverman DZ, Goldstein R. Lipid and vitamin E malabsorption in cirrhosis. Proceedings of 2nd Spanish-Israeli Liver Meeting, Toledo, Spain, 1995.
R e v i e w s, E d i t o r i a l s a n d B o o k C h a p t e r sֻ
36.Morali GA, Blendis LM. Causes and management of ascites. Trop Gastroenterology 11:186-201,1990.
37.Morali GA, Blendis LM. Treatment of ascites and its complications. Res Staff Physician 36(November):35-47,1990.
38.Morali GA, Blendis LM. What does "reduced central blood volume in cirrhosis" really mean? (Editorial) Hepatology 12:615-7,1990.
39.Blendis LM, Legault L, Morali GA, Warner LC, Logan AG, Skorecki KL. The role of ANF in ascites. In: Liver diseases and renal complications. Eds Gentolini, Arias, Arroyo & Schrier. Raven Press, New York pp 263-76,1990.
40.Morali GA, Blendis LM. Splenomegaly in portal hypertension: causes and effects. In: Portal Hypertension. Eds K Okuda & JP Benhamou. Springler-Verlag, Tokyo pp 85-101,1991.
41.Morali GA, Blendis LM. Ascites: why and how to treat. Medicine North America 16(February):2032-47,1991.
42.Morali GA, Blendis LM. Abnormal renal sodium handling in pre-ascitic cirrhosis: the role of ANF. J Clin Nutr Gastroenterol 6:41-6,1991.
43.Blendis LM, Morali GA, Legault L, Tobe S, Floras JL, Skorecki K. Natriuretic factors. Gastroenterology International 5:257-61,1992.
44.Morali GA, Blendis LM. Drug therapy in cirrhosis: novel approaches. In: Extracellular matrix. Eds M Zern & LM Reid. Dekker Inc, New York pp 383-399,1993.
45.Morali GA, Blendis LM. The liver in cardiac diseases. In: The liver in systemic diseases. Edds VK Rustgi & D Van Thiel. Raven Press, New York pp 23-42,1993.
46.Morali GA. Aspects cliniques et ethiques des transplantations hepatiques. Rambam Judaica. November 1997 pp 145-150
47. Lurie Y, Beer-Gabel M, Morali G et al. Phlebotomy lowers serum ALT and alphafetoprotein levels in patients with chronic hepatitis C. Hepatology, 1996
N o n - M e d i c a l P u b l i c a t i o n s
1. Morali GA. Science et Torah: la quatrieme dimension. Jerusalem Post
22/1/92.
2. Morali GA. Torah et science dans la tradition. Jerusalem Post
29/1/92.
3. Morali GA. Un accident de la nature? Jerusalem Post 5/2/92.
4. Morali GA. L'apparition de la vie. Jerusalem Post 12/2/92.
5. Thesis for a PhD in Philosophy (Universitי la Sorbonne Paris I): Ethique et concretude. Essai sur la corporיite dans la pensee d’Emmmanuel Lיvinas, Paris 1999

עיסוק במחקר מדעי

Technique of transjugular biopsy (course in the splanchnic hemodynamic
unit in Hopital Beaujon, France, under the supervision of Dr Lebrec)
Lipid and vitamin E absorption in cirrhosis
Sodium balance in pre-ascitic cirrhosis
Management of patients with HCV antibodies and normal liver function tests (in collaboration with the liver unit - Hadassah Hospital, Israel)

מרפאת הפעמון

ירושלים, קינג ג'ורג' 3
זימון תורים 24 שעות ביממה 053-9956126
02-6233315